
DOI . ORG {
}
Title[redir]:
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma | Cancer Immunology, Immunotherapy
Description:
Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
Matching Content Categories {📚}
- Telecommunications
- Science
- Health & Fitness
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🏙️ Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 80,904,851 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We're unsure how the site profits.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.
Keywords {🔍}
article, google, scholar, cancer, pubmed, cas, cells, immunotherapy, macrophages, cellular, bartholeyns, vivo, cell, patients, tracking, activated, ovarian, mak, access, sites, carcinoma, monocytes, oncol, immunol, privacy, cookies, content, macrophage, prince, chokri, human, poindron, immunother, data, publish, research, search, killer, ritchie, mileshkin, wall, distribution, tumour, open, clin, clinical, adoptive, melbourne, information, log,
Topics {✒️}
month download article/chapter bispecific antibody mdx-h210 mdx-h210 bispecific antibody imaging cell trafficking human-activated macrophages produced large scale isolation induce anti-tumour responses stem cells article cancer immunology administered mak cells vivo cell labeling full article pdf privacy choices/manage cookies improved pet labels related subjects human macrophages produced activated macrophages proliferating activated macrophages grown metastatic ovarian carcinoma cellular cancer immunotherapies cell labelling epithelial ovarian carcinoma counterflow centrifugation elutriation car macrophages directs indium-labelled macrophages scope submit manuscript generating high numbers multi-dimensional characterization cytokine secretion profile human monocytes cultured anti-tumor properties de gramont topoisomerase ii-alpha romet-lemonne jl infarcted human myocardium 64cu-pyruvaldehyde-bis positron-emission tomography 6th framework programme diagnostic imaging conditions privacy policy potent antitumoral properties adoptive cellular immunotherapy cell radiolabelling european economic area demonstrate successful targeting human blood monocytes 18f-fdg limited 18f-fdg labelling cd64-directed immunotherapy compared antitumoral effects
Schema {🗺️}
WebPage:
mainEntity:
headline:In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
description:Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
datePublished:2006-05-30T00:00:00Z
dateModified:2006-05-30T00:00:00Z
pageStart:155
pageEnd:163
sameAs:https://doi.org/10.1007/s00262-006-0181-3
keywords:
Immunotherapy
Macrophage
Radiolabel
PET
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig4_HTML.jpg
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:56
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:D. Ritchie
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:L. Mileshkin
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:D. Wall
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Bartholeyns
affiliation:
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
type:Organization
type:Person
name:M. Thompson
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Coverdale
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:E. Lau
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Wong
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:P. Eu
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:R. J. Hicks
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:H. M. Prince
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
description:Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
datePublished:2006-05-30T00:00:00Z
dateModified:2006-05-30T00:00:00Z
pageStart:155
pageEnd:163
sameAs:https://doi.org/10.1007/s00262-006-0181-3
keywords:
Immunotherapy
Macrophage
Radiolabel
PET
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig4_HTML.jpg
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:56
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:D. Ritchie
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:L. Mileshkin
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:D. Wall
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Bartholeyns
affiliation:
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
type:Organization
type:Person
name:M. Thompson
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Coverdale
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:E. Lau
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:J. Wong
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:P. Eu
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:R. J. Hicks
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
type:Person
name:H. M. Prince
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:56
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:D. Ritchie
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
name:L. Mileshkin
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
name:D. Wall
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:J. Bartholeyns
affiliation:
name:Immuno-Designed Molecules
address:
name:Immuno-Designed Molecules, Paris, France
type:PostalAddress
type:Organization
name:M. Thompson
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:J. Coverdale
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:E. Lau
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:J. Wong
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:P. Eu
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:R. J. Hicks
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
name:H. M. Prince
affiliation:
name:Peter MacCallum Cancer Centre
address:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
type:PostalAddress
type:Organization
name:University of Melbourne
address:
name:University of Melbourne, Melbourne, Australia
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:Immuno-Designed Molecules, Paris, France
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
name:University of Melbourne, Melbourne, Australia
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(169)
- Find out how much https://link.springer.com/privacystatement earns monthly
- Discover the revenue of https://link.springer.com/article/10.1007/s00262-006-0181-3/#main
- How much does https://link.springer.com make?
- What's the monthly money flow for https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s00262-006-0181-3?
- What's the financial intake of https://link.springer.com/article/10.1007/s00262-006-0181-3/#eds-c-header-nav?
- How much does https://link.springer.com/journals/ bring in each month?
- How much money does https://www.springernature.com/gp/authors make?
- https://link.springernature.com/home/ income
- What's the monthly income of https://link.springer.com/article/10.1007/s00262-006-0181-3/#eds-c-header-popup-search?
- How much does https://order.springer.com/public/cart rake in every month?
- https://link.springer.com/article/10.1007/s00262-006-0181-3/'s revenue stream
- What's the income of https://link.springer.com/article/10.1007/s00262-006-0181-3/journal/262?
- Check the income stats for https://link.springer.com/article/10.1007/s00262-006-0181-3/#citeas
- What's https://link.springer.com/article/10.1007/s00262-006-0181-3/journal/262/aims-and-scope's gross income?
- Find out how much https://submission.nature.com/new-submission/262/3 earns monthly
- What's the income of https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-D_-Ritchie-Aff1-Aff4?
- Find out how much https://link.springer.com/article/10.1007/s00262-006-0181-3/#Aff1 earns monthly
- https://link.springer.com/article/10.1007/s00262-006-0181-3/#Aff4's revenue stream
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-L_-Mileshkin-Aff1-Aff4 pull in monthly?
- See how much https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-D_-Wall-Aff1 makes per month
- What's the monthly income of https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-J_-Bartholeyns-Aff2?
- Get to know what's the income of https://link.springer.com/article/10.1007/s00262-006-0181-3/#Aff2
- https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-M_-Thompson-Aff3's financial summary
- What's the profit of https://link.springer.com/article/10.1007/s00262-006-0181-3/#Aff3?
- https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-J_-Coverdale-Aff1 income
- What's the income generated by https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-E_-Lau-Aff3 each month?
- https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-J_-Wong-Aff3 income
- How profitable is https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-P_-Eu-Aff3?
- Financial intake of https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-R__J_-Hicks-Aff3-Aff4
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/#auth-H__M_-Prince-Aff1-Aff4 make?
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/article/10.1007/s00262-006-0181-3/metrics rake in every month?
- How much revenue does https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00262-006-0181-3 produce monthly?
- How much revenue does https://link.springer.com/product/springer-plus generate?
- What's the income of https://www.springernature.com/gp/librarians/licensing/agc/journals?
- Explore the financials of https://link.springer.com/10.1186/s12967-025-06521-3?fromPaywallRec=true
- Income figures for https://link.springer.com/10.1038/s41419-024-07267-4?fromPaywallRec=true
- How much does https://link.springer.com/10.1186/s12964-018-0229-y?fromPaywallRec=true rake in every month?
- What are the total earnings of https://link.springer.com/article/10.1007/s00262-006-0181-3/subjects/cellular-imaging?
- Earnings of https://link.springer.com/article/10.1007/s00262-006-0181-3/subjects/cell-delivery
- https://link.springer.com/article/10.1007/s00262-006-0181-3/subjects/flow-cytometry's total income per month
- Get to know https://link.springer.com/article/10.1007/s00262-006-0181-3/subjects/immune-cell-isolation's earnings
- How much income is https://link.springer.com/article/10.1007/s00262-006-0181-3/subjects/mammary-stem-cells earning monthly?
- How much income does https://link.springer.com/article/10.1007/s00262-006-0181-3/subjects/nk-cells have?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12805342 make?
- https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DC%2BD2cXpsVKjsL0%3D's total income per month
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Current%20developments%20in%20cancer%20vaccines%20and%20cellular%20immunotherapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2003.06.041&volume=21&pages=2415-2432&publication_year=2003&author=Ribas%2CA&author=Butterfield%2CLH&author=Glaspy%2CJA&author=Economou%2CJS
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15557385?
- What's http://scholar.google.com/scholar_lookup?&title=In%20vivo%20tracking%20of%20stem%20cells%20for%20clinical%20trials%20in%20cardiovascular%20disease&journal=Circulation&doi=10.1161%2F01.CIR.0000149840.46523.FC&volume=110&pages=3378-3384&publication_year=2004&author=Frangioni%2CJ&author=Hajjar%2CR's gross income?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1295473
- https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DyaK3sXitlWktLs%3D income
- How much does http://scholar.google.com/scholar_lookup?&title=Production%20of%20macrophages%20with%20potent%20antitumoral%20properties%20%28MAK%29%20by%20culture%20of%20monocytes%20in%20the%20presence%20of%20GM-CSF%20and%201%2C25%20%28OH%292%20vitD3&journal=Anticancer%20Res&volume=12&pages=2257-2260&publication_year=1992&author=Chokri%2CM&author=Lopez%2CM&author=Oleron%2CC&author=Girard%2CA&author=Martinache%2CC&author=Siffert%2CJC&author=Canepa%2CS&author=Bartholeyns%2CJ make?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2193096?
- What's the income of https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DyaK3cXksFOiurg%3D?
- How much does http://scholar.google.com/scholar_lookup?&title=Phagocytosis%20of%20tumor%20cells%20by%20human%20monocytes%20cultured%20in%20GM-CSF&journal=J%20Exp%20Med&doi=10.1084%2Fjem.172.1.231&volume=172&pages=231-237&publication_year=1990&author=Munn%2CD&author=Cheung%2CN make?
- Profit of http://scholar.google.com/scholar_lookup?&title=Therapy%20of%20cancer%20metastases%20by%20systemic%20activation%20of%20macrophages&journal=Res%20Immunol&doi=10.1016%2F0923-2494%2893%2980109-C&volume=144&pages=284-287&publication_year=1992&author=Fidler%2CI&author=Kleinerman%2CE
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3208813 earns monthly
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DyaL1M%2FptFalsw%3D%3D earn?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Control%20of%20the%20antitumoral%20activity%20of%20human%20macrophages%20produced%20in%20large%20amount%20in%20view%20of%20adoptive%20transfer&journal=Eur%20J%20Cancer%20Clin%20Oncol&doi=10.1016%2F0277-5379%2888%2990069-7&volume=24&pages=1691-1698&publication_year=1988&author=Dumont%2CS&author=Hartmann%2CD&author=Poindron%2CP&author=Faradji%2CA&author=Oberling%2CF&author=Bartholeyns%2CJ produce monthly?
- Explore the financials of https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtFSrtbbO
- See how much http://scholar.google.com/scholar_lookup?&title=Anti-tumor%20properties%20of%20human-activated%20macrophages%20produced%20in%20large%20scale%20for%20clinical%20application&journal=Immunobiol&doi=10.1016%2Fj.imbio.2005.05.021&volume=210&pages=267-277&publication_year=2005&author=Baron-Bodo%2CV&author=Doceur%2CP&author=Lefebvre%2CML&author=Labroqu%C3%A8re%2CK&author=Defaye%2CC&author=Cambouris%2CC&author=Prigent%2CD&author=Salcedo%2CM&author=Boyer%2CA&author=Nardin%2CA makes per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8083534 pull in monthly?
- How much profit is https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DyaK2czmsFCiuw%3D%3D making per month?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Large%20scale%20isolation%20of%20human%20blood%20monocytes%20by%20continuous%20flow%20centrifugation%20leukapheresis%20and%20counterflow%20centrifugation%20elutriation%20for%20adoptive%20cellular%20immunotherapy%20in%20cancer%20patients&journal=J%20Immunol%20Methods&doi=10.1016%2F0022-1759%2894%2990033-7&volume=174&pages=297-309&publication_year=1994&author=Faradji%2CA&author=Bohbot%2CA&author=Schmitt%2CM&author=Siffert%2CJ&author=Dumont%2CS&author=Wiesel%2CM&author=Piemont%2CY&author=Eischen%2CA&author=Bergerat%2CJ&author=Bartholeyns%2CJ&author=Poindron%2CP&author=Witz%2CJP&author=Oberling%2CF?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180139
- https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DyaL1M%2FivVCruw%3D%3D's financial summary
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Immunotherapy%20of%20cancer%3A%20experimental%20approach%20with%20activated%20macrophages%20proliferating%20in%20culture&journal=Cancer%20Detect%20Prev&volume=12&pages=413-420&publication_year=1988&author=Bartholeyns%2CJ&author=Lombard%2CY&author=Dumont%2CS&author=Hartmann%2CD&author=Chokri%2CM&author=Giaimis%2CJ&author=Kaufmann%2CS&author=Poindron%2CP?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2817800 have monthly?
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DyaK3cXlvFak generate monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=Compared%20antitumoral%20effects%20of%20LPS%2C%20TNF%2C%20interferon%20and%20activated%20macrophages%20on%20experimental%20tumors.%20Synergism%20and%20tissue%20distribution&journal=Anticancer%20Res&volume=9&pages=1185-1190&publication_year=1989&author=Chokri%2CM&author=Freudenberg%2CM&author=Galanos%2CC&author=Poindron%2CP&author=Bartholeyns%2CJ
- Check the income stats for https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DyaK38zosFCmsQ%3D%3D
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Adoptive%20immunotherapy%20with%20activated%20macrophages%20grown%20in%20vitro%20from%20blood%20monocytes%20in%20cancer%20patients%3A%20a%20pilot%20study&journal=J%20Immunotherapy&doi=10.1097%2F00002371-199204000-00008&volume=11&pages=209-217&publication_year=1992&author=Lopez%2CM&author=Fechtenbaum%2CJ&author=David%2CB&author=Martinache%2CC&author=Chokri%2CM&author=Canepa%2CS&author=De%20Gramont%2CA&author=Louvet%2CC&author=Gorin%2CI&author=Mortel%2CO&author=Bartholeyns%2CJ?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2045866 gross monthly?
- Explore the financials of https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DyaK3M3lvFWktQ%3D%3D
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Phase%20I%20study%20of%20liposomal%20PTP-PE-activated%20autologous%20monocytes%20administered%20intraperitoneally%20to%20patients%20with%20peritoneal%20carcinomatosis&journal=J%20Clin%20Oncol&volume=9&pages=1251-1260&publication_year=1991&author=Faradji%2CA&author=Bohbo%2CA&author=Frost%2CH&author=Schmitt-Goguel%2CM&author=Siffert%2CJC&author=Dufour%2CP&author=Eber%2CM&author=Lallot%2CC&author=Wiesel%2CML&author=Bergerat%2CJP&author=Oberling%2CF?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7545221
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DyaK2MXoslaqtb4%3D pull in?
- Profit of http://scholar.google.com/scholar_lookup?&title=Phase%20I%20trial%20of%20bispecific%20antibody%20MDX-H210%20in%20patients%20with%20advanced%20breast%20or%20ovarian%20cancer%20that%20overexpresses%20the%20proto-oncogene%20HER-a%20neu&journal=J%20Clin%20Oncol&volume=13&pages=2281-2292&publication_year=1995&author=Valone%2CF&author=Kaufman%2CP&author=Guyre%2CP
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14984957?
- How much profit is https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DC%2BD2cXhsVOns7Y%3D making per month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Rates%20of%20topoisomerase%20II-alpha%20and%20HER-2%20gene%20amplification%20and%20expression%20in%20epithelial%20ovarian%20carcinoma&journal=Gynecol%20Oncol&doi=10.1016%2Fj.ygyno.2003.12.010&volume=92&issue=3&pages=887-895&publication_year=2004&author=Mano%2CMS&author=Awada%2CA&author=Di%20Leo%2CA&author=Durbecq%2CV&author=Paesmans%2CM&author=Cardoso%2CF&author=Larsimont%2CD&author=Piccart%2CM produce monthly?
- Find out how much https://link.springer.com/doi/10.1007/s002620050435 earns monthly
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9435876
- How much profit does https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DyaK1cXitlamtQ%3D%3D generate?
- http://scholar.google.com/scholar_lookup?&title=Clinical%20experience%20with%20CD64-directed%20immunotherapy.%20An%20overview&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620050435&volume=45&pages=210-215&publication_year=1997&author=Curnow%2CRT's financial summary
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12079309?
- How much does http://scholar.google.com/scholar_lookup?&title=Adoptive%20immunotherapy%20of%20ovarian%20carcinoma&journal=Gynecol%20Oncol&volume=86&pages=102-103&publication_year=2002&author=Gramont%2CA&author=Gangji%2CD&author=Louvet%2CC&author=Garcia%2CML&author=Tardy%2CD&author=Romet-Lemonne%2CJL pull in?
- How much money does http://scholar.google.com/scholar_lookup?&title=Biodistribution%20of%20indium-labelled%20macrophages%20in%20mice%20bearing%20solid%20tumors&journal=Int%20J%20Immunother&volume=6&pages=79-84&publication_year=1990&author=Chokri%2CM&author=Lallot%2CC&author=Ebert%2CM&author=Poindron%2CP&author=Bartholeyns%2CJ make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10994674's revenue stream
- What's the profit of https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DC%2BD3cvksVaqtA%3D%3D?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=18F-FDG%20labelling%20of%20human%20leucocytes&journal=Nucl%20Med%20Commun&volume=21&pages=691-694&publication_year=2000&author=Forstrom%2CLA&author=Mullan%2CBP&author=Hung%2CJC&author=Lowe%2CVJ&author=Thorson%2CLM
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15851598 produce monthly?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Monitoring%20of%20bone%20marrow%20cell%20homing%20into%20the%20infarcted%20human%20myocardium&journal=Circulation&doi=10.1161%2F01.CIR.0000163546.27639.AA&volume=111&issue=17&pages=2198-2202&publication_year=2005&author=Hofmann%2CM&author=Wollert%2CKC&author=Meyer%2CGP&author=Menke%2CA&author=Arseniev%2CL&author=Hertenstein%2CB&author=Ganser%2CA&author=Knapp%2CWH&author=Drexler%2CH?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12944233 have?
- How profitable is https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:STN:280:DC%2BD3svgsFCltg%3D%3D?
- How much income is http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20cellular%20therapies%3A%20the%20Australian%20perspective&journal=Cytotherapy&doi=10.1080%2F14653240310002207&volume=5&issue=4&pages=284-288&publication_year=2003&author=Wall%2CDM&author=Prince%2CHM earning monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11867752 each month?
- https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DC%2BD38Xit1Cru7k%3D income
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Ex%20vivo%20cell%20labeling%20with%2064Cu-pyruvaldehyde-bis%28N4-methylthiosemicarbazone%29%20for%20imaging%20cell%20trafficking%20in%20mice%20with%20positron-emission%20tomography&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.052709599&volume=99&pages=3030-3035&publication_year=2002&author=Adonai%2CN&author=Nguyen%2CKN&author=Walsh%2CJ&author=Iyer%2CM&author=Toyokuni%2CT&author=Phelps%2CME&author=McCarthy%2CT&author=McCarthy%2CDW&author=Gambhir%2CSS
- What is the monthly revenue of https://link.springer.com/doi/10.1007/s002620100224?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11761442 pull in monthly?
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DC%2BD38Xjsl2jtQ%3D%3D net monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Biodistribution%20of%20111indium-labeled%20macrophages%20infused%20intravenously%20in%20patients%20with%20renal%20carcinoma&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620100224&volume=50&issue=9&pages=477-482&publication_year=2001&author=Quillien%2CV&author=Moisan%2CA&author=Lesimple%2CT&author=Leberre%2CC&author=Toujas%2CL earning monthly?
- What is the earnings of https://link.springer.com/doi/10.1007/s00262-003-0390-y?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12690521 is on a monthly basis
- https://link.springer.com/article/10.1007/s00262-006-0181-3/articles/cas-redirect/1:CAS:528:DC%2BD3sXkvFynu74%3D income
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Injection%20by%20various%20routes%20of%20melanoma%20antigen-associated%20macrophages%3A%20biodistribution%20and%20clinical%20effects&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-003-0390-y&volume=52&issue=7&pages=438-444&publication_year=2003&author=Lesimple%2CT&author=Moisan%2CA&author=Carsin%2CA&author=Ollivier%2CI&author=Mousseau%2CM&author=Meunier%2CB&author=Leberre%2CC&author=Collet%2CB&author=Quillien%2CV&author=Drenou%2CB&author=Lefeuvre-Plesse%2CC&author=Chevrant-Breton%2CJ&author=Toujas%2CL?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-006-0181-3?format=refman&flavour=references pull in monthly?
- How much revenue does https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=D.%20Ritchie bring in?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Ritchie have monthly?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Ritchie%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=L.%20Mileshkin rake in every month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L.%20Mileshkin bring in?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L.%20Mileshkin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the monthly income of https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=D.%20Wall?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Wall?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Wall%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit is https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=J.%20Bartholeyns making per month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Bartholeyns pull in?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Bartholeyns%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Discover the revenue of https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=M.%20Thompson
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Thompson?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Thompson%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much money does https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=J.%20Coverdale make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Coverdale's total income per month
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Coverdale%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What are the earnings of https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=E.%20Lau?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Lau
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Lau%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=J.%20Wong net monthly?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Wong is on a monthly basis
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Wong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=P.%20Eu's gross income?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=P.%20Eu?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22P.%20Eu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Get to know https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=R.%20J.%20Hicks's earnings
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20J.%20Hicks?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20J.%20Hicks%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://link.springer.com/article/10.1007/s00262-006-0181-3/search?sortBy=newestFirst&dc.creator=H.%20M.%20Prince's financial summary
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.%20M.%20Prince generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.%20M.%20Prince%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Get to know what's the income of https://link.springer.com/article/10.1007/s00262-006-0181-3/mailto:[email protected]
- Learn how profitable https://s100.copyright.com/AppDispatchServlet?title=In%20vivo%20tracking%20of%20macrophage%20activated%20killer%20cells%20to%20sites%20of%20metastatic%20ovarian%20carcinoma&author=D.%20Ritchie%20et%20al&contentID=10.1007%2Fs00262-006-0181-3©right=Springer-Verlag&publication=0340-7004&publicationDate=2006-05-30&publisherName=SpringerNature&orderBeanReset=true is on a monthly basis
- How much cash flow does https://citation-needed.springer.com/v2/references/10.1007/s00262-006-0181-3?format=refman&flavour=citation have monthly?
- See how much https://link.springer.com/article/10.1007/s00262-006-0181-3/search?query=Immunotherapy&facet-discipline="Medicine%20%26%20Public%20Health" makes per month
- What's the profit of https://link.springer.com/article/10.1007/s00262-006-0181-3/search?query=Macrophage&facet-discipline="Medicine%20%26%20Public%20Health"?
- How much does https://link.springer.com/article/10.1007/s00262-006-0181-3/search?query=Radiolabel&facet-discipline="Medicine%20%26%20Public%20Health" bring in each month?
- https://link.springer.com/article/10.1007/s00262-006-0181-3/search?query=PET&facet-discipline="Medicine%20%26%20Public%20Health" income
- Financial intake of https://link.springer.com/journals/a/1
- Get to know https://link.springer.com/books/a/1's earnings
- Earnings of https://link.springer.com/journals
- Profit of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- Get to know https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's earnings
- How much revenue does https://www.springernature.com/gp/products produce monthly?
- How much does https://www.springernature.com/gp/librarians pull in?
- Learn about the earnings of https://www.springernature.com/gp/societies
- How much does https://www.springernature.com/gp/partners make?
- What is the monthly revenue of https://www.springer.com/?
- How profitable is https://www.nature.com/?
- How much profit does https://www.biomedcentral.com/ generate?
- How much does https://www.palgrave.com/ generate monthly?
- How profitable is https://www.apress.com/?
- Revenue of https://link.springer.com/brands/discover
- Check the income stats for https://www.springernature.com/gp/legal/ccpa
- What's the income generated by https://www.springernature.com/gp/info/accessibility each month?
- What's the financial outcome of https://link.springer.com/termsandconditions?
- Profit of https://support.springernature.com/en/support/home
- What's the income of https://link.springer.com/legal-notice?
- Revenue of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- What's the financial outcome of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref